Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Batten disease: four genes and still counting.

¹Department of Paediatrics, University College London Medical School, United Kingdom.

Neurobiology of Disease

|March 9, 1999

Summary

Neuronal ceroid lipofuscinoses (NCLs), or Batten disease, are common childhood neurodegenerative disorders. Genetic research is revealing the molecular basis of NCLs, paving the way for treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Epitope mapping.

Methods in molecular biology (Clifton, N.J.)·2012

Same author

Epitope mapping.

Methods in molecular biology (Clifton, N.J.)·2012

Same author

Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses.

Current pharmaceutical biotechnology·2011

Same author

CLN5 mutations are frequent in juvenile and late-onset non-Finnish patients with NCL.

Neurology·2010

Same author

Adult neuronal ceroid lipofuscinosis caused by deficiency in palmitoyl protein thioesterase 1.

Neurology·2007

Same author

A CLN5 mutation causing an atypical neuronal ceroid lipofuscinosis of juvenile onset.

Neurology·2005

Area of Science:

Genetics
Neuroscience
Biochemistry

Background:

Neuronal ceroid lipofuscinoses (NCLs), also known as Batten disease, represent the most prevalent group of inherited neurodegenerative disorders affecting children.
These conditions are defined by the accumulation of autofluorescent storage material within various cell types, leading to progressive neurological decline.
Clinical manifestations vary by NCL type, typically including seizures, psychomotor deterioration, and eventual blindness.

Purpose of the Study:

To elucidate the genetic underpinnings of NCL subtypes.
To understand the molecular mechanisms driving NCL pathogenesis.
To identify potential therapeutic targets for Batten disease.

Main Methods:

Utilizing molecular genetics to identify causative genes for distinct NCL phenotypes.
Investigating the function of identified genes to understand their role in cellular processes.
Correlating genetic defects with observed clinical features.

Main Results:

Recognition of an increasing number of NCL subtypes linked to mutations in different genes.
Identification of four NCL-associated genes to date.
Functional characterization of two genes suggests a primary defect in lysosomal proteolysis.

Conclusions:

The molecular basis of NCLs may involve lysosomal proteolysis, representing a novel disease category.
The identification of causative genes is crucial for understanding NCL pathogenesis and developing treatments.
Further research is needed as the function of some identified genes remains unknown, and additional genes are yet to be discovered, indicating potential complexity beyond current understanding.

Related Experiment Videos